Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | SLO | ENG

Naslov:Lung cancer biomarker testing : perspective from Europe
Avtorji:Thunnissen, Erik (Avtor)
Weynand, Birgit (Avtor)
Udovicic-Gagula, Dalma (Avtor)
Brčić, Luka (Avtor)
Szolkowska, Malgorzata (Avtor)
Hofman, Paul (Avtor)
Smojver-Ježek, Silvana (Avtor)
Anttila, Sisko (Avtor)
Calabrese, Fiorella (Avtor)
Kern, Izidor (Avtor)
Jezik:Angleški jezik
Tipologija:1.02 - Pregledni znanstveni članek
Organizacija:Logo UKPBAG - Univerzitetna klinika za pljučne bolezni in alergijo Golnik
Povzetek:A questionnaire on biomarker testing previously used in central European countries was extended and distributed in Western and Central European countries to the pathologists participating at the Pulmonary Pathology Society meeting 26-28 June 2019 in Dubrovnik, Croatia. Each country was represented by one responder. For recent biomarkers the availability and reimbursement of diagnoses of molecular alterations in non-small cell lung carcinoma varies widely between different, also western European, countries. Reimbursement of such assessments varies widely between unavailability and payments by the health care system or even pharmaceutical companies. The support for testing from alternative sources, such as the pharmaceutical industry, is no doubt partly compensating for the lack of public health system support, but it is not a viable or long-term solution. Ideally, a structured access to testing and reimbursement should be the aim in order to provide patients with appropriate therapeutic options. As biomarker enabled therapies deliver a 50% better probability of outcome success, improved and unbiased reimbursement remains a major challenge for the future.
Ključne besede:lung neoplasms -- diagnosis -- therapy -- Europe, lung cancer, predictive testing
Leto izida:2020
Založnik:AME Publishing
Izvor:Kitajska
UDK:616-006
ISSN pri članku:2226-4477
OceCobissID:17120003 Povezava se odpre v novem oknu
COBISS_ID:28071683 Povezava se odpre v novem oknu
Opombe:Nasl. z nasl. zaslona; Soavtor iz Slovenije: Izidor Kern; Opis vira z dne 11. 9. 2020;
Število ogledov:907
Število prenosov:606
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (1,80 MB)
URL URL - Izvorni URL, za dostop obiščite http://tlcr.amegroups.com/article/view/40413/pdf
 
Nadgradivo:Transl. lung cancer res.
Pioneer Bioscience
 
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
Avtorske pravice:© Translational Lung Cancer Research
:
  
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.


Licence

Licenca:CC BY-NC-ND 4.0, Creative Commons Priznanje avtorstva-Nekomercialno-Brez predelav 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by-nc-nd/4.0/deed.sl
Opis:Najbolj omejujoča licenca Creative Commons. Uporabniki lahko prenesejo in delijo delo v nekomercialne namene in ga ne smejo uporabiti za nobene druge namene.
Začetek licenciranja:27.05.2020

Nazaj